Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
Low
3.45
High
9.10
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Eupraxia Pharmaceuticals Inc | EPRX | Toronto | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.09 | 2.50% | 3.69 | 14:59:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.78 | 3.45 | 3.78 | 3.69 | 3.60 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 97 | 166,876 | - | 3.45 - 9.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:59:00 | 200 | $ 3.69 | CAD |
Eupraxia Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 79.68M | 21.59M | - | 0 | -23.26M | -1.08 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Eupraxia Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.81 | 3.90 | 3.45 | 3.68 | 65,166 | -0.12 | -3.15% |
| 1 Month | 4.58 | 4.79 | 3.45 | 3.96 | 63,993 | -0.89 | -19.43% |
| 3 Months | 5.46 | 7.64 | 3.45 | 4.63 | 68,590 | -1.77 | -32.42% |
| 6 Months | 6.12 | 7.64 | 3.45 | 4.87 | 41,113 | -2.43 | -39.71% |
| 1 Year | 4.90 | 9.10 | 3.45 | 5.96 | 35,750 | -1.21 | -24.69% |
| 3 Years | 6.12 | 9.10 | 0.80 | 4.21 | 26,048 | -2.43 | -39.71% |
| 5 Years | 7.75 | 9.10 | 0.80 | 4.29 | 26,236 | -4.06 | -52.39% |
Eupraxia Pharmaceuticals Description
| Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. |
